DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Anuh Pharma Limited — Updates

NSE 2 hrs ago·13 Oct 2026, 1:24 pm

Anuh Pharma

Anuh Pharma Limited has informed stock exchanges that it is considering a proposal to invest in a new business venture and is also seeking to avail a loan. This development signals the company's intent to expand its operations or strengthen its financial position through external funding.

For investors, this news is important as it indicates potential growth opportunities or strategic shifts within the company. However, the specific details of the investment and the terms of the loan remain undisclosed, which means the impact on the company's financials is currently uncertain.

Investors should keep an eye on the company's future announcements for clarity on the nature of the investment and the loan's purpose. Monitoring the stock's reaction to further updates will be key to understanding the market's view on this proposed move.